Jason N. Butler
Stock Analyst at Citizens
(3.48)
# 914
Out of 5,131 analysts
11
Total ratings
63.64%
Success rate
5.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jason N. Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ACHV Achieve Life Sciences | Initiates: Market Outperform | $19 | $5.47 | +247.35% | 1 | Nov 25, 2025 | |
| RAPP Rapport Therapeutics | Maintains: Market Outperform | $77 → $80 | $28.31 | +182.59% | 1 | Nov 7, 2025 | |
| WULF TeraWulf | Maintains: Market Outperform | $18 → $22 | $12.84 | +71.34% | 1 | Oct 29, 2025 | |
| RZLT Rezolute | Maintains: Market Outperform | $9 → $17 | $2.37 | +617.30% | 1 | Oct 29, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Market Outperform | $95 → $114 | $115.49 | -1.29% | 1 | Sep 25, 2025 | |
| CRMD CorMedix | Reiterates: Market Outperform | $22 | $7.51 | +192.94% | 1 | Sep 9, 2025 | |
| CYTK Cytokinetics | Reiterates: Market Outperform | $78 | $63.32 | +23.18% | 1 | Sep 2, 2025 | |
| PGEN Precigen | Maintains: Market Outperform | $6 → $8 | $4.61 | +73.54% | 1 | Aug 19, 2025 | |
| ZVRA Zevra Therapeutics | Maintains: Market Outperform | $19 → $18 | $8.63 | +108.57% | 1 | Aug 13, 2025 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Market Outperform | $30 → $35 | $26.91 | +30.06% | 1 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $91 → $78 | $72.13 | +8.14% | 1 | Aug 6, 2025 |
Achieve Life Sciences
Nov 25, 2025
Initiates: Market Outperform
Price Target: $19
Current: $5.47
Upside: +247.35%
Rapport Therapeutics
Nov 7, 2025
Maintains: Market Outperform
Price Target: $77 → $80
Current: $28.31
Upside: +182.59%
TeraWulf
Oct 29, 2025
Maintains: Market Outperform
Price Target: $18 → $22
Current: $12.84
Upside: +71.34%
Rezolute
Oct 29, 2025
Maintains: Market Outperform
Price Target: $9 → $17
Current: $2.37
Upside: +617.30%
ABIVAX Société Anonyme
Sep 25, 2025
Maintains: Market Outperform
Price Target: $95 → $114
Current: $115.49
Upside: -1.29%
CorMedix
Sep 9, 2025
Reiterates: Market Outperform
Price Target: $22
Current: $7.51
Upside: +192.94%
Cytokinetics
Sep 2, 2025
Reiterates: Market Outperform
Price Target: $78
Current: $63.32
Upside: +23.18%
Precigen
Aug 19, 2025
Maintains: Market Outperform
Price Target: $6 → $8
Current: $4.61
Upside: +73.54%
Zevra Therapeutics
Aug 13, 2025
Maintains: Market Outperform
Price Target: $19 → $18
Current: $8.63
Upside: +108.57%
ACADIA Pharmaceuticals
Aug 7, 2025
Maintains: Market Outperform
Price Target: $30 → $35
Current: $26.91
Upside: +30.06%
Aug 6, 2025
Maintains: Market Outperform
Price Target: $91 → $78
Current: $72.13
Upside: +8.14%